Healthcare organizations are investing rapidly in AI and advanced analytics, yet many struggle to translate clinical data into tools that are safe, equitable, and useful in real care settings.

First-of-its-kind, cloud-native AI platform for transplant program cohort analysis, clinical research, and real-world evidence generation announced at the 2026 Precision Medicine World Conference ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Most healthcare organizations already have access to much of the data they need, but the challenge is operationalizing it ...

The HealthVerity agreement is the latest in a series of data partnerships through which Thermo Fisher has been expanding its ...

PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced that Recursion (NASDAQ: RXRX), a leading ...

BALTIMORE, MD, UNITED STATES, April 3, 2026 /EINPresswire.com/ -- Through her contributions to Data-Driven Healthcare, ...

The global market for clinical data analytics is expected to grow at a compound annual growth rate of 12.5 percent by 2023, according to a Market Research Future report. Clinical data analytics ...

CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets First-of-its-kind, cloud-native AI ...